Jose Portoles, Maria Luisa Serrano Salazar, Olga González Peña, Sandra Gallego Domínguez, Manel Vera Rivera, Jara Caro Espada, Alba Herreros García, Maria Antonia Munar Vila, Maria José Espigares Huete, Haridian Sosa Barrios, Vicente Paraíso, Loreto Mariscal de Gante, Maria Auxiliadora Bajo, Antonia Gueorguieva Mijaylova, Elena Pascual Pajares, Nuria Areste Fosalba, Laura Espinel, Fernando Tornero Molina, Soledad Pizarro Sánchez, Mayra Ortega Díaz, Aleix Cases, Borja Quiroga
BACKGROUND: Current guidelines establish the same hemoglobin (Hb) and iron biomarkers targets for hemodialysis (HD) and peritoneal dialysis (PD) in patients receiving erythropoiesis-stimulating agents (ESAs) even though patients having PD are usually younger, more active and less comorbid. Unfortunately, specific renal anemia [anemia in chronic kidney disease (aCKD)] trials or observational studies on PD are scanty. The aims of this study were to describe current aCKD management, goals and adherence to clinical guidelines, identifying opportunities for healthcare improvement in PD patients...
December 2023: Clinical Kidney Journal